Completed
An Open Label Phase I Dose Escalation Study of E7080 Administered to Patients With Solid Tumors
NCT00280397
- Conditions
- Cancer: Solid Tumors, Neoplasms
- Locations
-
- Tokyo, Japan
Clinical trial condition
Explore clinical trials studying Cancer: Solid Tumors. Study availability and eligibility vary by location and protocol.
NCT00280397